Phase 1 trial of carfilzomib + melphalan (CarMel) conditioning and autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma (MM) Meeting Abstract
| Authors: | Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y. B.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S. A. |
| Abstract Title: | Phase 1 trial of carfilzomib + melphalan (CarMel) conditioning and autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma (MM) |
| Meeting Title: | 2014 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 20 |
| Issue: | 2 Suppl. 1 |
| Meeting Dates: | 2014 Feb 26-Mar 2 |
| Meeting Location: | Grapevine, TX |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2014-02-01 |
| Start Page: | S159 |
| End Page: | S160 |
| Language: | English |
| ACCESSION: | WOS:000331155400232 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2013.12.254 |
| Notes: | Poster Session I; Meeting Abstract: 227 -- BMT Tandem Meetings -- FEB 26-MAR 02, 2014 -- Grapevine, TX -- 1 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
